|Articles|August 1, 2018

BioPharm International

  • BioPharm International-08-01-2018
  • Volume 31
  • Issue 8

BioPharm International, August 2018 Issue (PDF)

Click the title above to open the BioPharm International August 2018 issue in an interactive PDF format.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 7 years ago

The Search for Next-Gen Expression Systems

over 7 years ago

FDA Is Not Playing Games with Biosimilars

over 7 years ago

Expectations for Residual Impurity Analysis Continue to Rise

over 7 years ago

E&L Risk Assessment for Biologic Drug Products

over 7 years ago

Submitting Extractables and Leachables Data to Regulators

over 7 years ago

A New Paradigm in Drug Development

over 7 years ago

Maintaining Cell Line Integrity

over 7 years ago

FDA Seeks to Revive Quality Metrics Initiative

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!